Cabot Corporation (CBT) Stock Price & Analysis
Cabot Corporation (CBT) closed at USD 74.33 on Thursday, October 22, 2026, up 0.75% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 73.78; the Oct 22, 2026 session ranged USD 73.43–74.52 on volume of 338,628 shares. Market capitalization is $3.84B, with a 52-week range of USD 58.33–94.53 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CBT.md
Key facts (CBT)
- Last four reported quarters (through Jun 30, 2026): revenue $3.63B, net income $190M (5.2% margin), free cash flow $281M (SEC filings).
- Valuation: P/E 20.2x (avg 12.6x at the last 3 fiscal year-ends), EV/EBITDA 6.9x, net debt $839M.
- 1 of 80 tracked superinvestors hold CBT (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (6 analysts), mean target USD 90.33 (range 78–100).
- Total return with dividends: 1Y +7.1% vs S&P 500 +14.9%; 5Y +53.9% vs S&P 500 +80.3%.
- Next earnings: 2026-11-02, EPS estimate USD 1.54, revenue estimate $927M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CBT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.41B | $4.32B | $3.93B | $3.99B | $3.71B | $3.63B |
| Gross profit | $799M | $885M | $839M | $960M | $940M | — |
| Operating income | $454M | $389M | $526M | $614M | $621M | $493M |
| Net income | $250M | $209M | $445M | $380M | $331M | $190M |
| EPS (diluted) | $4.34 | $3.62 | $7.73 | $6.72 | $6.02 | — |
| Free cash flow | $62.0M | -$111M | $351M | $451M | $391M | $281M |
| Gross margin | 23.4% | 20.5% | 21.3% | 24.0% | 25.3% | — |
| Operating margin | 13.3% | 9.0% | 13.4% | 15.4% | 16.7% | 13.6% |
| Net margin | 7.3% | 4.8% | 11.3% | 9.5% | 8.9% | 5.2% |
| Revenue growth | +30.4% | +26.8% | -9.0% | +1.6% | -7.0% | — |
| Cash + short-term investments | $168M | $206M | $238M | $223M | $258M | — |
| Total debt | $1.09B | $1.10B | $1.10B | $1.09B | $1.12B | — |
Fiscal years end Sep. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CBT)
P/E 20.2x · P/S 1.1x · EV/EBITDA 6.9x · EV/Sales 1.3x · P/FCF 13.7x · P/B 2.4x · FCF yield 7.32% · Earnings yield 4.95% · Dividend yield (paid, TTM) 2.53% · Buyback yield (TTM) 3.65% · Net debt $839M · EV $4.68B
P/E at fiscal year-ends: Sep 2025 12.5x, Sep 2024 16.4x, Sep 2023 8.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (CBT)
1 of 80 tracked investors hold CBT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.03% | $18.9M | Added +52.5% |
Analysts (CBT)
Consensus Hold (mean 3.00 on a 1–5 scale), 6 analysts; mean target USD 90.33 (low 78, high 100).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-05 | UBS | Target lowered | Neutral | $92 → $86 |
| 2026-08-07 | JP Morgan | Target raised | Underweight | $70 → $78 |
| 2026-08-05 | UBS | Target lowered | Neutral | $97 → $92 |
| 2026-06-25 | Mizuho | Target raised | Neutral | $80 → $90 |
Total return (dividends reinvested) (CBT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +7.1% | +53.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +7.1% | +9.0% |
| Volatility (annualized) | 32.7% | 30.3% |
| Max drawdown | -20.9% (Jun 2026→Oct 2026) | -45.4% (Nov 2024→Nov 2025) |
Companies that name CBT in their SEC reports
| Relationship to CBT | Company | Filing | Sentence |
|---|---|---|---|
| partner | USA Rare Earth, Inc. (USAR) | 10-K Mar 30, 2026 | “In 1987, Cyprus Metals Company ("Cyprus") entered into a joint venture with Cabot and took over the project.” |
| partner | ASPEN AEROGELS INC (ASPN) | 10-K Mar 13, 2026 | “Cross License Agreement with Cabot Corporation” |
| partner | 3M CO (MMM) | 10-K Feb 3, 2026 | “Aearo could potentially be exposed to additional claims for some part of the pre-July 11, 1995, period covered by its agreement with Cabot if Aearo elects to discontinue its participation in this arrangement, or if Cabot is no longer able to meet its obligations in these matters.” |
CBT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.54 | $1.52 | +1.5% | $927.3M | 5 |
| Next quarter (ends Dec 2026) | $1.59 | $1.57 | +1.4% | $877.0M | 1 |
| Current fiscal year (ends Sep 2026) | $6.37 | $6.32 | +0.7% | $3.69B | 6 |
| Next fiscal year (ends Sep 2027) | $6.99 | $7.03 | -0.6% | $3.80B | 6 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 74.33 |
|---|---|
| Change | ▲ 0.75% (up) |
| Previous Close | USD 73.78 |
| Open | USD 73.6 |
| Day Range | USD 73.43 – 74.52 |
| 52-Week Range | USD 58.33 – 94.53 |
| Volume | 338,628 shares |
| Market Cap | $3.84B |
| Exchange | NYQ |
Technical Analysis (CBT)
Nexqual's technical model rates CBT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.89 (neutral) |
| vs SMA50 | Below (USD 79.4) |
| MACD | -1.58 (negative) |
Analyst Ratings (CBT)
Wall Street analysts rate CBT "Hold" based on 6 analysts, with a mean price target of USD 90.33 (range USD 78–100), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 90.33 |
| High Target | USD 100 |
| Low Target | USD 78 |
| Buy / Hold / Sell | 2 / 3 / 1 |
Earnings (CBT)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 1.54 |
| Revenue Estimate | $927.34M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.67 vs est 1.66 ▲ beat |
| 2026-03-31 | USD 1.61 vs est 1.47 ▲ beat |
| 2025-12-31 | USD 1.53 vs est 1.38 ▲ beat |
| 2025-09-30 | USD 1.7 vs est 1.68 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (CBT)
| Total Revenue | $3.63B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +6.40% |
| Gross Margin | +24.22% |
| Operating Margin | +14.26% |
| Profit Margin | +5.23% |
| ROE | +13.35% |
| Debt / Equity | 0.74 |
| Current Ratio | 1.47 |
| Total Cash | $250.00M |
| Total Debt | $1.29B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $281.00M (7.7% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (CBT)
Nexqual rates Cabot Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Weak — Revenue -7% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 14% (last 12 months) |
| Balance Sheet | Solid — $250M cash and investments vs $1.09B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $281M (last 4 quarters to Jun 2026, SEC), 8% margin |
| Efficiency | Mixed — ROE 13%, ROA 8.9% |
Ownership (CBT)
| Insider Ownership | +1.35% |
|---|---|
| Institutional Ownership | +105.98% |
| Shares Outstanding | 51.63M |
| Float | 50.86M |
| Short % of Float | +11.69% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (CBT)
Cabot Corporation is led by Erica J. McLaughlin C.P.A., President, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| President, CEO & Director | Erica J. McLaughlin C.P.A. |
|---|---|
| Executive VP, President of Carbon & Silica Technologies, Battery Materials and Asia Pacific Region | Jeff Ji Zhu |
| VP, Treasurer & Interim CFO | Steven J. Delahunt |
| Senior VP & CTO | Patricia A. Hubbard |
| Vice President of Investor Relations & Corporate Planning | Robert Rist |
Major Backers & Investors (CBT)
Notable institutional backers of Cabot Corporation include Earnest Partners LLC, American Century Companies Inc, Wellington Management, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Earnest Partners LLC | 6.48% |
| American Century Companies Inc | 5.36% |
| Wellington Management | 4.68% |
| Fuller & Thaler Asset Management Inc. | 3.88% |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 3.14% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 13.51% |
| Vanguard Group | 10.46% |
| State Street | 4.19% |
| Dimensional Fund Advisors | 3.73% |
| Geode Capital | 3.45% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCPC | Balchem Corporation | USD 173.23 | ▲ 1.43% |
| SXT | Sensient Technologies Corporati | USD 130.94 | ▼ 0.95% |
| EMN | Eastman Chemical Company | USD 65.31 | ▲ 2.85% |
| AXTA | Axalta Coating Systems Ltd. | USD 35.05 | ▲ 0.2% |
| WLK | Westlake Corporation | USD 64.14 | ▲ 5.42% |
| NEU | NewMarket Corp | USD 876.33 | ▼ 0.98% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt